A controlled study of facial mobility treatment in Parkinson's disease
- PMID: 8736419
- DOI: 10.1016/0022-3999(95)00611-7
A controlled study of facial mobility treatment in Parkinson's disease
Abstract
The aim of this study was to evaluate the effects of orofacial physiotherapeutic treatment (OPT) on the facial mobility of Parkinson's disease (PD) sufferers. Sixteen participants with PD were allocated randomly to either the Treatment group or the Control group. A short interview between the physiotherapist and each subject was videotaped, and 10 random frames of the videotape were selected to be used in the facial expression assessment. The quantification of facial expressions was achieved by using an objective microcomputer-based measurement system, based on a mathematical model of the face (FACEM). A facial outline is obtained, as well as 12 facial measures, which represent distances between key facial landmarks. The facial assessment was performed on 3 separate occasions, that is, baseline (pretreatment), posttreatment, and follow-up (4 weeks later). A repeated measures analysis of variance (MANOVA) revealed a significant main effect of Time and a significant interaction effect between Time and Group for the Mouth-Opening Measure, suggesting that after treatment, members of the Treatment group opened their mouths to a greater degree than members of the Control group. Within the Treatment group, significant differences between pretreatment and posttreatment scores (MANOVA) were found for Mouth-Opening Measure and Mid-Top-Lip Measure. Similarly, Mouth-Opening Measure, Mid-Top-Lip Measure, Lower-Lip Thickness Measure, Top Eyelid/Iris Intersect Measure and Lower Eyelid/Iris Intersect Measure were significant across time from baseline to follow-up in the Treatment group only. No significant differences were found on any of the facial measures during the same period for members of the Control group. These findings suggest that OPT can improve facial movement and that this benefit extends in time, beyond the period of OPT itself. Such an increase in facial mobility can be expected to modify the "Parkinsonian facies" and facilitate the display of facial expressions.
Similar articles
-
A controlled quantitative study of facial expression in Parkinson's disease and depression.J Nerv Ment Dis. 1991 Nov;179(11):683-8. doi: 10.1097/00005053-199111000-00006. J Nerv Ment Dis. 1991. PMID: 1940892
-
A study of facial expression in Parkinson's disease using a novel microcomputer-based method.J Neurol Neurosurg Psychiatry. 1988 Mar;51(3):362-6. doi: 10.1136/jnnp.51.3.362. J Neurol Neurosurg Psychiatry. 1988. PMID: 3361329 Free PMC article.
-
An objective evaluation method for facial mimic motion.Otolaryngol Head Neck Surg. 1996 Jan;114(1):27-31. doi: 10.1016/S0194-59989670279-6. Otolaryngol Head Neck Surg. 1996. PMID: 8570246
-
Facial rehabilitation: a neuromuscular reeducation, patient-centered approach.Facial Plast Surg. 2008 May;24(2):250-9. doi: 10.1055/s-2008-1075841. Facial Plast Surg. 2008. PMID: 18470837 Review.
-
Facial Rehabilitation: Evaluation and Treatment Strategies for the Patient with Facial Palsy.Otolaryngol Clin North Am. 2018 Dec;51(6):1151-1167. doi: 10.1016/j.otc.2018.07.011. Epub 2018 Sep 24. Otolaryngol Clin North Am. 2018. PMID: 30262166 Review.
Cited by
-
The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson's Disease.Brain Sci. 2024 Jan 22;14(1):109. doi: 10.3390/brainsci14010109. Brain Sci. 2024. PMID: 38275529 Free PMC article. Review.
-
Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches.Neurol Sci. 2016 Mar;37(3):431-6. doi: 10.1007/s10072-015-2421-9. Epub 2015 Nov 21. Neurol Sci. 2016. PMID: 26590993 Clinical Trial.
-
Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review.Eur J Pain. 2022 Nov;26(10):2036-2059. doi: 10.1002/ejp.2031. Epub 2022 Sep 16. Eur J Pain. 2022. PMID: 36063442 Free PMC article.
-
Sensorimotor regulation of facial expression - An untouched frontier.Neurosci Biobehav Rev. 2024 Jul;162:105684. doi: 10.1016/j.neubiorev.2024.105684. Epub 2024 May 6. Neurosci Biobehav Rev. 2024. PMID: 38710425 Free PMC article. Review.
-
Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD002812. doi: 10.1002/14651858.CD002812.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895930 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical